CSOP Hang Seng Biotech ETF (03174.HK) fell 1.65% to HKD 3.450

Newtimespace News, as of 09:32 on May 11, CSOP Hang Seng Biotech ETF (03174.HK) was quoted at HKD 3.450, down 1.65%. The ETF opened at HKD 3.500, with a high of HKD 3.500 and a low of HKD 3.450. The latest NAV per unit is HKD 3.510, with a premium rate of -0.04%. The asset size is approximately HKD 891 million.

CSOP Hang Seng Biotech ETF (03174.HK) is a passive ETF product issued by CSOP Asset Management Limited. The primary investment objective of this ETF is to track the performance of the Hang Seng Biotech Index. The ETF's constituent holdings broadly cover sub-categories such as pharmaceuticals, biotechnology, pharmaceutical distribution, and medical equipment & supplies, focusing on leading companies in core areas like innovative drugs, CXO (Contract Research, Development and Manufacturing Organizations), and medical devices.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.